Physician profile
Andrew Benedict
NPI 1962943399
$4,347.10
in general payments reported to CMS, 2019-2025
14 companies · $578 in 2025
The $578 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,121 · 2020: $373 · 2021: $424 · 2022: $759 · 2023: $801 · 2024: $291 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,670.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,190.37 | 2019-2021 | |
| Coopervision INC. | $619.96 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Onefit Contact Lens |
| Alcon Vision LLC | $612.48 | 2019-2023 | Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $569.97 | 2022-2025 | Infuse, Miebo, Biotrue |
| Sun Pharmaceutical Industries INC. | $295.85 | 2022-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $234.48 | 2019-2025 | Acuvue |
| Sight Sciences, INC. | $153.25 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $137.62 | 2021-2025 | Acthar |
| Zimmer Biomet Holdings, INC. | $136.91 | 2025 | Ribfix Titan |
| Oyster Point Pharma, INC. | $97.32 | 2023-2024 | Tyrvaya |
| Dompe US, INC. | $90.65 | 2023 | Oxervate |
| Glaukos Corporation | $85.49 | 2020 | |
| Aerie Pharmaceuticals, INC. | $73.83 | 2019 | |
| Abbvie INC. | $48.92 | 2022-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Benedict listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.